- Home
- FUN vs ICUI Comparison
FUN vs ICUI Comparison
Compare FUN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUN
- ICUI
- Stock Information
- Founded
- FUN 1983
- ICUI 1984
- Country
- FUN United States
- ICUI United States
- Employees
- FUN N/A
- ICUI N/A
- Industry
- FUN Services-Misc. Amusement & Recreation
- ICUI Medical/Dental Instruments
- Sector
- FUN Consumer Discretionary
- ICUI Health Care
- Exchange
- FUN Nasdaq
- ICUI Nasdaq
- Market Cap
- FUN 3.5B
- ICUI 3.4B
- IPO Year
- FUN 1987
- ICUI 1992
- Fundamental
- Price
- FUN $30.35
- ICUI $127.74
- Analyst Decision
- FUN Strong Buy
- ICUI Strong Buy
- Analyst Count
- FUN 15
- ICUI 5
- Target Price
- FUN $48.73
- ICUI $196.75
- AVG Volume (30 Days)
- FUN 2.1M
- ICUI 198.1K
- Earning Date
- FUN 08-07-2025
- ICUI 08-06-2025
- Dividend Yield
- FUN N/A
- ICUI N/A
- EPS Growth
- FUN N/A
- ICUI N/A
- EPS
- FUN N/A
- ICUI N/A
- Revenue
- FUN $2,809,368,000.00
- ICUI $2,420,093,000.00
- Revenue This Year
- FUN $25.36
- ICUI N/A
- Revenue Next Year
- FUN $4.42
- ICUI N/A
- P/E Ratio
- FUN N/A
- ICUI N/A
- Revenue Growth
- FUN 54.72
- ICUI 7.22
- 52 Week Low
- FUN $28.02
- ICUI $111.97
- 52 Week High
- FUN $58.70
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- FUN 37.17
- ICUI 39.54
- Support Level
- FUN $29.07
- ICUI $125.78
- Resistance Level
- FUN $33.14
- ICUI $133.85
- Average True Range (ATR)
- FUN 1.24
- ICUI 3.34
- MACD
- FUN -0.26
- ICUI -0.32
- Stochastic Oscillator
- FUN 27.12
- ICUI 15.71
About FUN Cedar Fair L.P.
Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.